| Insider Shares | 1,485,651,632 shares |
Insider Sentiment Score
The Insider Sentiment Score finds the companies being bought by corporate insiders.
It is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of insider accumulation. The scoring model uses a combination of the net number of insiders buying the prior 90 days, the total shares bought as a percentage of float, and the total shares owned by insiders. The number ranges from 0 to 100, with higher numbers indicating a higher level of accumulation to its peers, and 50 being the average.
Update Frequency: Daily
See Insiders Top Picks, which provides a list of companies with highest insider accumulation.
Officer Sentiment Score
The Officer Sentiment Score finds companies being bought by Corporate Officers.
By definition Corporate Officers are Corporate Insiders, but unlike some of the other Insiders (10% Shareholders and Board Members), Officers work for the company on a daily basis, and they user their own money when trading. (10% Shareholders and Board Members are often fund managers managing other people’s money.) As such, insider trades made by Officers are much more significant and should be treated appropriately.
Like the Insider Sentiment Score, the Officer Sentiment Score is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of officer accumulation.
Update Frequency: Daily
See Insiders Top Picks, which provides a list of companies with highest insider sentiment.
Key Insider Metrics
This card shows how the company ranks along various insider metrics. The percentile rank shows how this company compares to other companies in the US markets. Higher rankings are indicative of better situations.
For example, it is generally accepted that insider buying is a positive indicator, so companies with more insider buying would rank higher than companies with less insider buying (or even insider selling).
Net Number of Insiders Buying (Rank)
N/A
Net Number of Insiders Buying is the total number of insiders buying minus the total number of insiders selling in the last 90 days. The percentile rank is shown here (range from 0 to 100%).
Percent of Float Bought by Insiders (Rank)
N/A
Percent of Float Bought by Insiders is the total number of shares purchased by insiders minus the total number of shares sold by insiders in the last 90 days, divided by the total float and multiplied by 100.
Insider Trading Chart
Celsus Therapeutics insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Roster and Profitability Metrics
This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings. Additionally, when possible we provide the historical trade performance for the insider. The historical trade performance is a weighted average of the performance of actual open-market purchase transactions made by the insider. For more information on how this is calculated, watch this YouTube webinar.
See our leaderboard of most profitable insider traders.
| Insider | Avg Profit (%) | Shares Owned |
Split Adjusted |
|---|
Report errors via our new Insider Auditing Tool
Track Records of Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CLTX / Celsus Therapeutics. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Track Records of Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CLTX / Celsus Therapeutics. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical .
The following table shows the most recent open market sales that were not part of an automatic trading plan.
| Trade Date | Insider | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Transaction History
Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-29 | 2025-08-25 | 4 | Gaslightwala Abizer | AKTX | American Depositary Shares representing Ordinary Shares | D | 0.9000 | 3,000 | 3 | 298,574 | ||||
| 2025-08-29 | 2025-08-22 | 4 | Gaslightwala Abizer | AKTX | American Depositary Shares representing Ordinary Shares | D | 0.9300 | 8,000 | 7 | 295,574 | ||||
| 2025-08-29 | 2025-08-21 | 4 | Gaslightwala Abizer | AKTX | American Depositary Shares representing Ordinary Shares | D | 0.9400 | 10,000 | 9 | 287,574 | ||||
| 2025-06-25 | 2025-06-24 | 4 | Gaslightwala Abizer | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.1600 | 5,203 | 6 | 277,574 | ||||
| 2025-06-25 | 2025-06-23 | 4 | Gaslightwala Abizer | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.1500 | 943 | 1 | 272,371 | ||||
| 2025-06-24 | 2025-06-20 | 4 | Gaslightwala Abizer | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.2000 | 10,000 | 12 | 271,428 | ||||
| 2025-06-20 | 2025-06-17 | 4 | Gaslightwala Abizer | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.2000 | 15,000 | 18 | 261,428 | ||||
| 2025-06-16 | 2025-06-13 | 4 | Gaslightwala Abizer | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.1900 | 25,000 | 30 | 246,428 | ||||
| 2025-06-16 | 2025-06-12 | 4 | Gaslightwala Abizer | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.2300 | 20,000 | 25 | 221,428 | ||||
| 2025-06-12 | 2025-06-10 | 4 | Gaslightwala Abizer | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.2700 | 20,000 | 25 | 201,428 | ||||
| 2025-04-29 | 2025-03-06 | 4 | Patel Sandip I | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.1200 | 44,642 | 50 | 496,499 | ||||
| 2025-03-10 | 2025-03-06 | 4 | Huh Hoyoung | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.1200 | 892,857 | 1,000 | 4,695,854 | ||||
| 2025-03-10 | 2025-03-06 | 4 | Gaslightwala Abizer | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.1200 | 133,928 | 150 | 181,428 | ||||
| 2025-03-10 | 2025-03-06 | 4 | Bazemore Robert B | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.1200 | 44,642 | 50 | 44,642 | ||||
| 2025-03-10 | 2025-03-06 | 4 | Neal James R | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.1200 | 4,464 | 5 | 36,271 | ||||
| 2025-03-10 | 2025-03-06 | 4 | Patel Samir Rashmikant PranaBio Investments LLC | AKTX | American Depositary Shares representing Ordinary Shares | I | 1.1200 | 406,250 | 455 | 3,031,005 | ||||
| 2025-03-10 | 2025-03-06 | 4 | Prudo Ray | AKTX | American Depositary Shares representing Ordinary Shares | D | 1.1200 | 446,428 | 500 | 2,484,990 | ||||
| 2025-02-07 | 2025-01-10 | 4/A | Gaslightwala Abizer | AKTX | American Depository Shares representing Ordinary Shares | D | 1.2200 | 11,640 | 14 | 47,500 | ||||
| 2025-01-13 | 2025-01-10 | 4 | Hombeck Torsten | AKTX | American Depository Shares representing Ordinary Shares | D | 1.2200 | 200 | 0 | 200 | ||||
| 2025-01-13 | 2025-01-10 | 4 | Gaslightwala Abizer | AKTX | American Depository Shares representing Ordinary Shares | D | 1.2200 | 11,439 | 14 | 35,860 | ||||
| 2025-01-10 | 2025-01-09 | 4 | Neal James R | AKTX | Ordinary Shares, par value $0.0001 per share | D | 0.0006 | 8,000,000 | 5 | 32,216,000 | ||||
| 2025-01-07 | 2025-01-03 | 4 | Gaslightwala Abizer | AKTX | Ordinary Shares, par value $0.0001 per share | D | 0.0006 | 1,720,000 | 1 | 71,720,000 | ||||
| 2025-01-07 | 2025-01-03 | 4 | Patel Samir Rashmikant PranaBio Investments LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 0.0006 | 208,000 | 0 | 5,249,511,500 | ||||
| 2024-12-30 | 2024-12-27 | 4 | Patel Samir Rashmikant PranaBio Investments LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 0.0005 | 400,000 | 0 | 5,249,303,500 | ||||
| 2024-12-30 | 2024-12-26 | 4 | Patel Samir Rashmikant PranaBio Investments LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 0.0005 | 3,200,000 | 2 | 5,248,903,500 | ||||
| 2024-12-30 | 2024-12-27 | 4 | Gaslightwala Abizer | AKTX | Ordinary Shares, par value $0.0001 per share | D | 0.0005 | 40,000,000 | 20 | 70,000,000 | ||||
| 2024-12-27 | 2024-12-24 | 4 | Patel Samir Rashmikant PranaBio Investments LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 0.0005 | 7,500,000 | 4 | 5,245,703,500 | ||||
| 2024-12-27 | 2024-12-26 | 4 | Gaslightwala Abizer | AKTX | Ordinary Shares, par value $0.0001 per share | D | 0.0005 | 30,000,000 | 15 | 30,000,000 | ||||
| 2024-12-26 | 2024-12-20 | 4 | Patel Samir Rashmikant PranaBio Investments LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 0.0005 | 1,400,000 | 1 | 5,236,803,500 | ||||
| 2024-12-26 | 2024-12-23 | 4 | Patel Samir Rashmikant PranaBio Investments LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 0.0005 | 1,400,000 | 1 | 5,238,203,500 | ||||
| 2024-12-26 | 2024-12-23 | 4 | Neal James R | AKTX | Ordinary Shares, par value $0.0001 per share | D | 0.0005 | 2,000,000 | 1 | 24,216,000 | ||||
| 2024-12-03 | 2024-12-02 | 4 | Patel Samir Rashmikant PranaBio Investments LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 0.0012 | 419,286,000 | 503 | 5,235,403,500 | ||||
| 2024-12-03 | 2024-12-02 | 4 | Prudo Ray | AKTX | Ordinary Shares, par value $0.0001 per share | D | 0.0012 | 419,286,000 | 503 | 4,077,124,600 | ||||
| 2024-11-22 | 3 | Huh Hoyoung | AKTX | Ordinary Shares, par value $0.0001 per share | D | 7,605,994,000 | ||||||||
| 2024-11-22 | 3 | Huh Hoyoung By Hannol Ventures LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 218,914,000 | ||||||||
| 2024-11-22 | 3 | Neal James R | AKTX | Ordinary Shares, par value $0.0001 per share | D | 22,216,000 | ||||||||
| 2024-11-22 | 3 | Patel Sandip I | AKTX | Ordinary Shares, par value $0.0001 per share | D | 903,714,000 | ||||||||
| 2024-11-22 | 3 | Patel Sandip I By Davis Island Ventures LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 40,438,000 | ||||||||
| 2024-11-22 | 3 | Patel Sandip I By Quest Bio LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 39,760,000 | ||||||||
| 2024-11-22 | 3 | Patel Sandip I By Innovative Lifesci Investments LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 27,802,000 | ||||||||
| 2024-11-22 | 3 | Patel Sandip I By TT Insurance Investment LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 12,500,000 | ||||||||
| 2024-11-18 | 2024-11-14 | 4 | Patel Samir Rashmikant PranaBio Investments LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 1,404,622,000 | 4,816,117,500 | ||||||
| 2024-07-02 | 2024-06-30 | 4 | Patel Samir Rashmikant | AKTX | Ordinary Shares, par value $0.0001 per share | D | 91,396,000 | 91,396,000 | ||||||
| 2024-06-04 | 2024-05-31 | 4 | Prudo Ray | AKTX | Ordinary Shares, par value $0.0001 per share | D | 0.0009 | 1,326,258,000 | 1,194 | 3,657,838,600 | ||||
| 2024-06-04 | 2024-05-31 | 4 | Patel Samir Rashmikant PranaBio Investments LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 0.0009 | 1,326,258,000 | 1,194 | 3,411,495,500 | ||||
| 2024-05-03 | 2024-05-01 | 4 | DICICCO WENDY F | AKTX | Ordinary Shares, par value $0.0001 per share | D | 158,473,915 | 158,473,915 | ||||||
| 2024-04-30 | 2024-04-26 | 4 | Jacques Rachelle Suzanne | AKTX | Ordinary Shares, par value $0.0001 per share | D | 479,569,892 | 1,018,027,792 | ||||||
| 2024-01-02 | 3 | Jacques Rachelle Suzanne | AKTX | Ordinary Shares, par value $0.0001 per share | D | 538,457,900 | ||||||||
| 2024-01-02 | 3 | Patel Samir Rashmikant PranaBio Investments LLC | AKTX | Ordinary Shares, par value $0.0001 per share | I | 2,085,237,500 | ||||||||
| 2024-01-02 | 3 | Prudo Ray Praxis Trustees Limited | AKTX | Ordinary Shares, par value $0.0001 per share | I | 38,709,600 | ||||||||
| 2024-01-02 | 3 | Prudo Ray | AKTX | Ordinary Shares, par value $0.0001 per share | D | 2,331,580,600 | ||||||||
| 2024-01-02 | 3 | Prudo Ray RPC Pharma Limited | AKTX | Ordinary Shares, par value $0.0001 per share | I | 800,766,600 | ||||||||
| 2024-01-02 | 3 | Grissinger Michael | AKTX | Ordinary Shares, par value $0.0001 per share | D | 20,000,000 | ||||||||
| 2024-01-02 | 3 | WILLIAMS DONALD A | AKTX | Ordinary Shares, par value $0.0001 per share | D | 20,000,000 | ||||||||
| 2016-06-30 | 2016-06-29 | 4 | Williams Donald Allen | AKTX | Options to Purchase Ordinary Shares | D | 0.15 | 1,300,000 | 1,300,000 | |||||
| 2016-06-30 | 2016-06-29 | 4 | Williams Donald Allen | AKTX | Options to Purchase Ordinary Shares | D | 0.15 | 1,300,000 | 1,300,000 | |||||
| 2016-06-30 | 2016-06-29 | 4 | Cohen Mark S | AKTX | Options to Purchase Ordinary Shares | D | 0.15 | 1,300,000 | 1,300,000 | |||||
| 2016-06-30 | 2016-06-29 | 4 | Hill James | AKTX | Options to Purchase Ordinary Shares | D | 0.15 | 1,300,000 | 1,300,000 | |||||
| 2016-06-30 | 2016-06-29 | 4 | Ungar Stuart | AKTX | Options to Purchase Ordinary Shares | D | 0.15 | 1,300,000 | 1,300,000 | |||||
| 2016-06-30 | 2016-06-29 | 4 | Byrne David | AKTX | Options to Purchase Ordinary Shares | D | 0.15 | 1,300,000 | 1,300,000 | |||||
| 2016-04-26 | 2016-04-22 | 4 | Byrne David | AKTX | Options to Purchase Ordinary Shares | D | 17.96 | 1,300,000 | 1,300,000 | |||||
| 2016-03-25 | 2016-03-23 | 4 | SHAW ROBERT M | AKTX | Options to Purchase Ordinary Shares | D | 14.10 | 1,800,000 | 1,800,000 | |||||
| 2015-11-25 | 2015-11-25 | 4 | Ungar Stuart | AKTX | Options to Purchase Ordinary Shares | D | 0.19 | 1,088,722 | 1,088,722 | |||||
| 2015-11-25 | 2015-11-25 | 4 | Hill James | AKTX | Options to Purchase Ordinary Shares | D | 0.19 | 1,068,722 | 1,068,722 | |||||
| 2015-11-25 | 2015-11-25 | 4 | Shaw Allan | AKTX | Options to Purchase Ordinary Shares | D | 0.19 | 1,068,722 | 1,068,722 | |||||
| 2015-11-25 | 2015-11-25 | 4 | Cohen Mark S | AKTX | Options to Purchase Ordinary Shares | D | 0.19 | 1,028,722 | 1,028,722 | |||||
| 2015-09-23 | 3 | Prudo Ray | AKTX | Ordinary Shares | I | 1,444,691,200 | ||||||||
| 2015-09-23 | 3 | Prudo Ray | AKTX | Ordinary Shares | I | 1,444,691,200 | ||||||||
| 2015-09-23 | 3 | Richardson Clive | AKTX | No securities beneficially owned. | D | 0 | ||||||||
| 2015-09-23 | 3 | Ungar Stuart | AKTX | Ordinary Shares | I | 1,444,691,200 | ||||||||
| 2015-09-23 | 3 | Ungar Stuart | AKTX | Ordinary Shares | I | 1,444,691,200 | ||||||||
| 2015-09-23 | 3 | RPC Pharma Ltd | AKTX | Ordinary Shares | D | 1,444,691,200 | ||||||||
| 2015-09-23 | 3 | RPC Pharma Ltd | AKTX | Ordinary Shares | D | 1,444,691,200 | ||||||||
| 2015-09-23 | 3 | Hill James | AKTX | Ordinary Shares | I | 1,444,691,200 | ||||||||
| 2015-09-23 | 3 | Hill James | AKTX | Ordinary Shares | I | 1,444,691,200 | ||||||||
| 2015-09-23 | 2015-09-21 | 4 | Shaw Allan | AKTX | Options to Purchase Ordinary Shares | D | 0.32 | 186,278 | 186,278 | |||||
| 2015-09-23 | 2015-09-21 | 4 | Shaw Allan | AKTX | Options to Purchase Ordinary Shares | D | 0.32 | 45,000 | 45,000 | |||||
| 2015-09-23 | 2015-09-21 | 4 | Hill James | AKTX | Options (right to buy) | D | 0.32 | 231,278 | 231,278 | |||||
| 2015-09-23 | 2015-09-21 | 4 | Richardson Clive | AKTX | Options (right to buy) | D | 0.32 | 16,271,850 | 16,271,850 | |||||
| 2015-09-23 | 2015-09-21 | 4 | Ungar Stuart | AKTX | Options (right to buy) | D | 0.32 | 211,278 | 211,278 | |||||
| 2015-09-22 | 2015-09-21 | 4 | Cohen Mark S | AKTX | Options to Purchase Ordinary Shares | D | 0.32 | 186,278 | 186,278 | |||||
| 2015-09-22 | 2015-09-21 | 4 | Cohen Mark S | AKTX | Options to Purchase Ordinary Shares | D | 0.32 | 85,000 | 85,000 | |||||
| 2015-09-22 | 2015-09-18 | 4 | Cohen Mark S | AKTX | Ordinary Shares | D | 0.1895 | 1,055,600 | 200 | 1,055,600 | ||||
| 2015-09-22 | 2015-09-21 | 4 | Elefant Dov | AKTX | Options to Purchase Ordinary Shares | D | 0.32 | 4,067,963 | 4,067,963 | |||||
| 2015-09-22 | 2015-09-21 | 4 | Roshwalb Gur | AKTX | Options to Purchase Ordinary Shares | D | 0.32 | 32,543,700 | 32,543,700 | |||||
| 2015-01-12 | 2015-01-08 | 4 | Cohen Mark S Call options to purchase from Prof. Saul Yedgar | CLTX | Options to Purchase Ordinary Shares | I | 0.02 | -152,000 | 0 | |||||
| 2015-01-12 | 2015-01-08 | 4 | Cohen Mark S Call options to purchase from Prof. Saul Yedgar | CLTX | Options to Purchase Ordinary Shares | I | 0.02 | -50,700 | 0 | |||||
| 2015-01-12 | 2015-01-08 | 4 | Cohen Mark S | CLTX | Ordinary Shares | D | 0.0153 | 152,000 | 2 | 152,000 | ||||
| 2015-01-12 | 2015-01-08 | 4 | Cohen Mark S | CLTX | Ordinary Shares | D | 0.0167 | 50,700 | 1 | 50,700 | ||||
| 2015-01-02 | 3 | Cohen Mark S | CLTX | Ordinary Shares | D | 2,779,114 | ||||||||
| 2015-01-02 | 3 | Cohen Mark S | CLTX | Ordinary Shares | D | 2,779,114 | ||||||||
| 2015-01-02 | 3 | Roshwalb Gur | CLTX | Ordinary Shares | D | 350,876 | ||||||||
| 2015-01-02 | 3 | Roshwalb Gur | CLTX | Ordinary Shares | D | 350,876 | ||||||||
| 2015-01-02 | 3 | Shaw Allan | CLTX | Ordinary Shares | D | 67,060 | ||||||||
| 2015-01-02 | 3 | Shaw Allan | CLTX | Ordinary Shares | D | 67,060 | ||||||||
| 2015-01-02 | 3 | SIDRANSKY DAVID | CLTX | Ordinary Shares | D | 109,464 | ||||||||
| 2015-01-02 | 3 | SIDRANSKY DAVID | CLTX | Ordinary Shares | D | 109,464 | ||||||||
| 2014-04-17 | 2014-04-15 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 5.0000 | 17,100 | 86 | 778,030 | ||||
| 2014-04-17 | 2014-04-14 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 5.2100 | 3,000 | 16 | 760,930 | ||||
| 2014-04-11 | 2014-04-11 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 5.1500 | 100 | 1 | 757,930 | ||||
| 2014-04-11 | 2014-04-10 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 5.2500 | 1,400 | 7 | 757,830 | ||||
| 2014-04-11 | 2014-04-09 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 5.5100 | 1,075 | 6 | 756,430 | ||||
| 2014-04-08 | 2014-04-08 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 5.3600 | 35,500 | 190 | 755,355 | ||||
| 2014-04-08 | 2014-04-07 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.0000 | 3,754 | 23 | 719,855 | ||||
| 2014-04-08 | 2014-04-07 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 5.6400 | 16,900 | 95 | 716,101 | ||||
| 2014-04-08 | 2014-04-04 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.0800 | 11,250 | 68 | 699,201 | ||||
| 2014-04-08 | 2014-04-04 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.0000 | 1,000 | 6 | 687,951 | ||||
| 2014-04-02 | 2014-04-02 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common stock | I | 6.1500 | 2,500 | 15 | 686,951 | ||||
| 2014-04-02 | 2014-04-01 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common stock | I | 6.1200 | 7,496 | 46 | 684,451 | ||||
| 2014-04-02 | 2014-04-01 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.0800 | 7,375 | 45 | 676,955 | ||||
| 2014-04-02 | 2014-04-01 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.1800 | 500 | 3 | 669,580 | ||||
| 2014-04-02 | 2014-03-31 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Shares | I | 6.3500 | 7,936 | 50 | 669,080 | ||||
| 2014-04-02 | 2014-03-17 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Shares | I | 6.6500 | 2,400 | 16 | 661,144 | ||||
| 2014-03-27 | 2014-03-27 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.6100 | 1,700 | 11 | 658,744 | ||||
| 2014-03-27 | 2014-03-26 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.6500 | 13,300 | 88 | 657,044 | ||||
| 2014-03-27 | 2014-03-26 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.8600 | 900 | 6 | 643,744 | ||||
| 2014-03-27 | 2014-03-25 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.9000 | 303 | 2 | 642,844 | ||||
| 2014-03-24 | 2014-03-24 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.7100 | 2,400 | 16 | 642,541 | ||||
| 2014-03-24 | 2014-03-21 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.8300 | 4,900 | 33 | 640,141 | ||||
| 2014-03-24 | 2014-03-20 | 4 | SABBY MANAGEMENT, LLC See Footnotes | CLTX | Common Stock | I | 6.9000 | 3,800 | 26 | 635,241 | ||||
| 2014-03-14 | 3 | Mintz Hal See Footnotes | CLTX | Common Stock | I | 1,262,882 | ||||||||
| 2014-03-14 | 3 | Mintz Hal See Footnotes | CLTX | Common Stock | I | 1,262,882 | ||||||||
| 2014-03-14 | 3 | Mintz Hal See Footnotes | CLTX | Common Stock | I | 1,262,882 | ||||||||
| 2014-03-14 | 3 | Mintz Hal See Footnotes | CLTX | Common Stock | I | 1,262,882 |
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)
